PCSK9 INHIBITION AS A NOVEL THERAPEUTIC TARGET FOR ALCOHOLIC LIVER DISEASE

被引：0

作者：

Lee, J. ^{[1
]}

Mukhopadhyay, P. ^{[1
]}

Matyas, C. ^{[1
]}

Trojnar, E. ^{[1
]}

Paloczi, J. ^{[1
]}

Yang, Y. R. ^{[1
]}

Blank, B. A. ^{[1
]}

Savage, C. ^{[1
]}

Sorokin, A. V. ^{[1
]}

Mehta, N. N. ^{[1
]}

Vendruscolo, J. C. M. ^{[1
]}

Koob, G. F. ^{[1
]}

Vendruscolo, L. F. ^{[1
]}

Pacher, P. ^{[1
]}

Lohoff, F. W. ^{[1
]}

机构：

[1] NIAAA, Sect Clin Genom & Expt Therapeut, NIH, Bethesda, MD USA

来源：

ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH | 2020年 / 44卷

关键词：

D O I：

暂无

中图分类号：

R194 [卫生标准、卫生检查、医药管理];

学科分类号：

摘要：

151

引用

页码：45 / 45

页数：1

共 50 条

[21] PCSK9 inhibition in PAD
Huynh, Karina
NATURE REVIEWS CARDIOLOGY, 2018, 15 (01) : 4 - 5
[22] PCSK9 and the Gut-Liver-Brain Axis: A Novel Therapeutic Target for Immune Regulation in Alcohol Use Disorder
Lee, Ji Soo
O'Connell, Emma M.
Pacher, Pal
Lohoff, Falk W.
JOURNAL OF CLINICAL MEDICINE, 2021, 10 (08)
[23] PCSK9 inhibition in PAD
Karina Huynh
Nature Reviews Cardiology, 2018, 15 : 4 - 5
[24] The promises of PCSK9 inhibition
Petrides, Francine
Shearston, Kate
Chatelais, Mathias
Guilbaud, Florian
Meilhac, Olivier
Lambert, Gilles
CURRENT OPINION IN LIPIDOLOGY, 2013, 24 (04) : 307 - 312
[25] Lipids and PCSK9 inhibition in chronic kidney disease
Schunk, S. J.
Fliser, D.
Speer, T.
NEPHROLOGE, 2020, 15 (05): : 285 - 292
[26] Update on PCSK9 inhibition
Katzmann, Julius L.
Custodis, Florian
Schirmer, Stephan H.
Laufs, Ulrich
HERZ, 2022, 47 (03) : 196 - 203
[27] PCSK9 inhibitors: Novel therapeutic agents for the treatment of hypercholesterolemia
Verbeek, Rutger
Stoekenbroek, Robert M.
Hovingh, G. Kees
EUROPEAN JOURNAL OF PHARMACOLOGY, 2015, 763 : 38 - 47
[28] PCSK9 IS A THERAPEUTIC TARGET IN KRAS-MUTANT COLORECTAL CANCER
Wong, Chi Chun
Wu, Jianlin
Chan, Lam-Shing
Ji, Fenfen
Kang, Wei
To, Ka Fai
Sung, Joseph J.
Yu, Jun
GASTROENTEROLOGY, 2021, 160 (06) : S64 - S64
[29] PCSK9: a new target for hypercholesterolemia
Cariou, B.
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2013, 27 : 16 - 16
[30] PCSK9 is a new target of FXR
Langhi, C.
Arnaud, L.
Jarnoux, Al
Krempf, M.
Costet, P.
Cariou, B.
DIABETES & METABOLISM, 2007, 33 : S39 - S39

← 1 2 3 4 5 →